Home > PJ (current issue) > Letters | Search

PJ Online homeThe Pharmaceutical Journal
Vol 274 No 7345 p452
16 April 2005

This article
Reprint   Photocopy

PDF 90K, Acrobat Reader

Letters

· General election
· EU services directive
· Repeat dispensing
· Community pharmacy
· New contract
· Charge refunds
· Technicians
· Antipsychotics
· Methadone
· The profession (2)
· Registration


Letters to the Editor

Methadone

Pregnant women should be carefully supervised

From Dr M. R. Mohan and Dr J. Guirguis

Babies of women who misuse opiates are more likely than others to be premature and of low birth weight. They may also show withdrawal symptoms after birth such as irritability, restlessness, tremor and a high pitched cry. These symptoms are collectively called “fetal absence syndrome”. The symptoms are delayed if the mother was taking methadone as opposed to heroin, because methadone has a longer half-life (one to two days).

Studies indicate that women in methadone maintenance programmes have pregnancies with a better outcome than opiate-dependent mothers without methadone therapy.1 In addition, women in these programmes show less risky injecting behaviour and lower rates of HIV infection because the methadone is prescribed as a liquid, which is formulated to discourage attempts to inject it. An influential meeting of experts in the US concluded that the safety and efficacy of methadone maintenance treatment has been unequivocally established.2

Methadone doses above 60mg per day are often required to prevent heroin use. However the starting doses should be determined by specialists and be adjusted according to the patient’s initial use in order to prevent accidental overdose.

Community pharmacists play a pivotal role in supervising the dispensing of methadone on a regular basis. However, one point of concern is morning sickness because it can cause vomiting of methadone soon after it is swallowed. Close liaison between community pharmacists and patients’ key workers is essential to achieve quick replacement prescriptions, address the prescribing of a safe antiemetic, and report immediately the patient drops out of treatment.

Mylavarapu Mohan
Clinician
Joseph Guirguis
Consultant Addiction Psychiatrist
Wolverhampton City NHS PCT

References

1. Ward J, Hall W, Mattick RP. (1999). Role of maintenance treatment in opioid dependence. Lancet 1999;353:221–6.
2. National Consensus Development Panel. Effective medical treatment of opiate addiction. JAMA 1998;280:1936–43.

Send your letter to The Editor

Previous Topic (Antipsychotics)
Next Topic (The profession)

Back to Top


©The Pharmaceutical Journal